Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The GABA-A receptor subunit alpha-1 (GABRA1) is a protein encoded by the GABRA1 gene. It is a subunit of the GABA-A receptor, a ligand-gated chloride channel that mediates fast inhibitory neurotransmission in the central nervous system. Activation of the receptor by GABA allows chloride ions to flow into neurons, hyperpolarizing the neuron membrane and inhibiting action potential firing. The alpha 1 subunit is crucial for the sedative/hypnotic effects of benzodiazepines and is a primary target of Z-drugs for sleep aids. Dysfunctions or mutations in GABRA1 have been linked to epilepsy syndromes.
Binding to the GABA-A receptor, enhancing GABA-mediated chloride ion influx, leading to neuronal hyperpolarization and inhibition of neuronal firing.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GABA-A Receptor Subunit Alpha 1 (GABRA1).